<p>Mice infected with HSV-1 were euthanized on day 6 post-infection. PLN and spleen tissue obtained were homogenized to obtain singe cell suspension. CD8 T cells were stimulated with immunodominant SSIEFARL peptide and pro-inflammatory cytokine producing PD-1<sup>high</sup> and PD-1<sup>medium</sup> CD8 T cells were determined by flow cytometery as described in the methods. A and B, Representative FACS plots gated on CD8 T cell and bar diagrams denote the proportion of IFN-γ, TNF-α and IL-2 producing PD-1<sup>medium</sup> and PD-1<sup>high</sup> CD8 T cells in PLN and spleen on day 6 post-infection, respectively. Data shown is representative of two similar experiments with five mice in each group/experiment. Statistical significance was det...
<p>Mice were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of live attenuated HSV1-Tat or ...
<p>(A) Proliferation of 5×10<sup>4</sup> CFSE-labeled HSV-specific CD4<sup>+</sup> T cells (gDT-II) ...
<p>Mice were infected i.v. with 1000 cfu LM-OVA and treated with anti-PD-L1 or control IgG. Eight da...
<p>Control (PBS) and pDC-depleted (DT) mice were infected in the footpad with HSV-1. Draining poplit...
<p>C57BL/6 mice were infected with 1×10<sup>6</sup> p.f.u of HSV-1 (KOS) in the hind footpad. Mice w...
<p><i>Ex-vivo</i> cytotoxicity of splenic PD-1<sup>high</sup> and PD-1<sup>medium</sup> CD8 T cells ...
<p>Mice from isotype and anti-PDL1 treated groups were euthanized on day 6 post-infection. Single ce...
<p>Anti-PDL-1 or Isotype matched antibody was intra-peritoneally administered on -1 and 3 days post ...
<p>Control (PBS) and pDC-depleted (DT) mice were infected i.v. with HSV-1 (1×10<sup>7</sup> pfu). Se...
<p>WT and TLR3<sup>−/−</sup> mice were infected in the footpad with HSV-1 (1×10<sup>5</sup> pfu). To...
<p>C57BL/6 mice were intra-peritoneally administered with either anti-PDL-1 or Isotype matched antib...
<p>C57BL/6 and PD-L1<sup>-/-</sup> mice were infected with FV. Multi-parameter flow cytometry was us...
<p>DCs from WT C57BL/6 mice were infected with 1 PFU/cell of HSV-CD80, parental virus, or mock-infec...
<p>A, OVA<sub>257–264</sub>/K<sup>b+</sup> splenic CD8 T cell population seven days after VSV-OVA in...
<p>Mice were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of live-attenuated HSV1-Tat or ...
<p>Mice were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of live attenuated HSV1-Tat or ...
<p>(A) Proliferation of 5×10<sup>4</sup> CFSE-labeled HSV-specific CD4<sup>+</sup> T cells (gDT-II) ...
<p>Mice were infected i.v. with 1000 cfu LM-OVA and treated with anti-PD-L1 or control IgG. Eight da...
<p>Control (PBS) and pDC-depleted (DT) mice were infected in the footpad with HSV-1. Draining poplit...
<p>C57BL/6 mice were infected with 1×10<sup>6</sup> p.f.u of HSV-1 (KOS) in the hind footpad. Mice w...
<p><i>Ex-vivo</i> cytotoxicity of splenic PD-1<sup>high</sup> and PD-1<sup>medium</sup> CD8 T cells ...
<p>Mice from isotype and anti-PDL1 treated groups were euthanized on day 6 post-infection. Single ce...
<p>Anti-PDL-1 or Isotype matched antibody was intra-peritoneally administered on -1 and 3 days post ...
<p>Control (PBS) and pDC-depleted (DT) mice were infected i.v. with HSV-1 (1×10<sup>7</sup> pfu). Se...
<p>WT and TLR3<sup>−/−</sup> mice were infected in the footpad with HSV-1 (1×10<sup>5</sup> pfu). To...
<p>C57BL/6 mice were intra-peritoneally administered with either anti-PDL-1 or Isotype matched antib...
<p>C57BL/6 and PD-L1<sup>-/-</sup> mice were infected with FV. Multi-parameter flow cytometry was us...
<p>DCs from WT C57BL/6 mice were infected with 1 PFU/cell of HSV-CD80, parental virus, or mock-infec...
<p>A, OVA<sub>257–264</sub>/K<sup>b+</sup> splenic CD8 T cell population seven days after VSV-OVA in...
<p>Mice were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of live-attenuated HSV1-Tat or ...
<p>Mice were inoculated intravaginally with 10<sup>3</sup> pfu/mouse of live attenuated HSV1-Tat or ...
<p>(A) Proliferation of 5×10<sup>4</sup> CFSE-labeled HSV-specific CD4<sup>+</sup> T cells (gDT-II) ...
<p>Mice were infected i.v. with 1000 cfu LM-OVA and treated with anti-PD-L1 or control IgG. Eight da...